Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro

World Journal of Gastroenterology

Volumn 15, Issue 4, 2009, Pages 431-440

  Pan, Guang Dong ^a   Yang, Jian Qing ^a   Yan, Lv Nan ^a   Chu, Guang Ping ^a   Liu, Qiang ^a   Xiao, Yi ^a   Yuan, Lin ^a  

^a LIUZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Multi drug resistance; RNA interference

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC G 418; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CELL STRAIN HEPG2; CELL SUSPENSION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FROZEN SECTION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULAR CLONING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 59249099399     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.431     Document Type: Article

References (35)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811
2. Tuschl T. RNA interference and small interfering RNAs. Chembiochem 2001; 2: 239-245
3. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25-33
4. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15: 188-200
5. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742-9747
6. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-1266
7. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002; 32: 107-108
8. Ling V. Multidrug resistance and P-glycoprotein expression. Ann N Y Acad Sci 1987; 507: 7-8
9. Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 4538-4542
10. Wang HJ, Lee H. [Surgical treatment of hepatocellular carcinoma] Korean J Gastroenterol 2005; 45: 247-257
11. Warmann S, Göhring G, Teichmann B, Geerlings H, Pietsch T, Fuchs J. P-glycoprotein modulation improves in vitro chemosensitivity in malignant pediatric liver tumors. Anticancer Res 2003; 23: 4607-4611
12. Stuart DD, Kao GY, Allen TM. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1. Cancer Gene Ther 2000; 7: 466-475
13. Chan JY, Chu AC, Fung KP. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. Life Sci 2000; 67: 2117-2124
14. Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE, Hafkemeyer P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology 2002; 36: 874-884
15. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003; 63: 1515-1519
16. Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003; 545: 144-150
17. Alemán C, Annereau JP, Liang XJ, Cardarelli CO, Taylor B, Yin JJ, Aszalos A, Gottesman MM. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res 2003, 63: 3084-3091
18. An DS, Xie Y, Mao SH, Morizono K, Kong SK, Chen IS. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther 2003; 14: 1207-1212
19. Barton GM, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA 2002; 99: 14943-14945
20. Holm PS, Lage H, Bergmann S, Jürchott K, Glockzin G, Bernshausen A, Mantwill K, Ladhoff A, Wichert A, Mymryk JS, Ritter T, Dietel M, Gänsbacher B, Royer HD. Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Res 2004; 64: 322-328
21. Shi Z, Liang YJ, Chen Z-S, Wang XW, Wang XH, Ding Y, Chen LM, Yang XP, Fu LW. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther 2006; 5: 39-47
22. Fuchs B, Zhang K, Schabel A, Bolander ME, Sarkar G. identification of twenty-two candidate markers for human osteogenic sarcoma. Gene 2001; 278: 245-252
23. Rubin Grandis J, Zeng Q, Drenning SD. Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 2000; 110: 868-874
24. Chen YB, Yu SH, Yan LN, Gou XH, Li DH, Zhao LY, Zhang SB. Construction of mdr1 Expression Vector and Detection of Its Expression in HepG2 Cells. Zhongguo Puwaijichu Yu Linchuang Zazhi 2005; 12: 254-257
25. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537-592
26. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58
27. Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res 2005; 11: 4487-4494
28. Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J (Engl) 2005; 118: 893-902
29. Yagüe E, Higgins CF, Raguz S. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. Gene Ther 2004; 11: 1170-1174
30. Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference. JAMA 2005; 293: 1367-1373
31. Stevenson M. Therapeutic potential of RNA interference. N Engl J Med 2004; 351: 1772-1777
32. Koper-Emde D, Herrmann L, Sandrock B, Benecke BJ. RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter. Biol Chem 2004; 385: 791-794
33. Karkare S, Daniel S, Bhatnagar D. RNA interference silencing the transcriptional message: aspects and applications. Appl Biochem Biotechnol 2004; 119: 1-12
34. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553
35. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2: 243-247